Treatment outcomes with purine nucleoside analog alone or with rituximab for hairy cell leukemia at first relapse.

To our knowledge, this is the largest study evaluating the role of R in treatment of relapsed HCL and suggests that there is no advantage to the addition of R to PNA therapy at the time of first re-treatment.